BioCentury
ARTICLE | Finance

Banker tracks

Biotech investor, banker and analyst personnel changes

May 27, 2013 7:00 AM UTC

Andrew Gitkin joined Piper Jaffray as a managing director and head of West Coast biotechnology investment banking. He was a senior investment banker in the life sciences group at Moelis & Co.

Stephane Bancel joined Flagship Venturesas a senior partner. He also is president and CEO of mRNA play Moderna Therapeutics Inc., which emerged from Flagship's VentureLabs incubator and debuted in December. Flagship has more than $900 million under management (see BioCentury, Dec. 6, 2012)...